Omar Niss, MD

Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Kim, TO; Geris, JM; Flanagan, JM; Grace, RF; Lambert, MP; O’Farrell, C; Rose, MJ; Shimano, KA; Niss, O; Neunert, C; Neufeld, EJ; Despotovic, JM; Scheurer, ME; Grimes, AB. Blood Advances. 2024; 8:5529-5538.

Community Health Worker and Mobile Health Programs to Help Young Adults with Sickle Cell Disease Transition to Using Adult Healthcare Services – the Comets Study; Results from Patient-Reported Outcomes at 6 Months. Jan, S; Steinway, C; Belton, T; Shults, J; Bennett, L; Griffis, H; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Boruchov, D; Barakat, L; Andemariam, B; Rubin, D; Smith-Whitley, K. Blood. 2024; 144:1066.

Underutilization of Disease-Modifying Therapies in Sickle Cell Disease: A Real-World Analysis from the ASH Research Collaborative Data Hub. Niss, O; Fenchel, M; Kingsley, E; Latham, TS; Malik, P; Quinn, CT. Blood. 2024; 144:2312.

Community Health Worker Engagement with Adolescents and Young Adults with Sickle Cell Disease: Findings from the Comets Study. Forrest, J; Steinway, C; Shaw, E; Jan, S; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Boruchov, D; Niss, O; Andemariam, B; Smith-Whitley, K; Trachtenberg, S; Belton, T. Blood. 2024; 144:617.

Longitudinal Assessment of Myocardial Fibrosis in Sickle Cell Disease. Niss, O; Morin, C; Lang, SM; Alsaied, T; Tasset, M; Malik, P; Quinn, CT. Blood. 2024; 144:799.

Individualized, PK-Guided Dosing of Hydroxyurea for Young Children with Sickle Cell Anemia: Final Results from the Hydroxyurea Optimization through Precision Study (HOPS). Appiah-Kubi, A; Jacob, SA; Heeney, MM; Piccone, CM; Niss, O; Quinn, CT; Fritch Lilla, SA; Quarmyne, M; Rampersad, A; Remiker, A; Tang, A; Dong, M; McElhinney, K; Tanzer, JR; McGann, PT. Blood. 2024; 144:175.

Improving Transition of Emerging Adults with Sickle Cell Disease to Adult Care through a Multidisciplinary Process: The Development of a Transition Clinic to Support Transition Success. Fenchel, L; Jackson, F; Walker, B; Manuel, C; Hooks, D; Allen, T; Thant, MM; Karkoska, K; Smart, LR; Joffe, NE; Niss, O. Blood. 2023; 142:5055.

Genetic Variants in Canonical Wnt Signaling Pathway Associated with Pediatric ITP. Kim, TO; Geris, JM; Grimes, AB; Grace, RF; Lambert, MP; Rose, MJ; Shimano, KA; Niss, O; Neunert, C; Nakano, TA; Kirk, SE; Despotovic, JM; Flanagan, JM; Scheurer, ME. Blood. 2023; 142:2593.

Congenital Dyserythropoietic Anemia Type II: An Update from the Congenital Dyseryhtropoietic Anemia Registry of North America (CDAR). Elgammal, Y; Risinger, M; Husami, A; Walden, J; Gupta, S; Shah, NC; Boyer, J; Abajas, YL; Winstead, M; Miller, DW; Lorsbach, R; Zhang, W; Kalfa, TA; Niss, O. Blood. 2023; 142:1079.

Individualized, PK-Guided Dosing of Hydroxyurea Is Not Associated with Increased Hematologic Toxicity Compared to Weight-Based Initial Dosing: Interim Results from the Hops Trial. Appiah-Kubi, A; Jacob, SA; Heeney, MM; Brown, C; Creary, SE; Hollenkamp, CR; Meier, ER; Niss, O; Piccone, CM; Quarmyne, M; Quinn, CT; Remiker, A; Saving, KL; Dong, M; McGann, PT. Blood. 2022; 140:5416-5417.